Back to Search
Start Over
Tumor elastography and its association with cell-free tumor DNA in the plasma of breast tumor patients: a pilot study
- Source :
- Quant Imaging Med Surg
- Publication Year :
- 2021
- Publisher :
- AME Publishing Company, 2021.
-
Abstract
- BACKGROUND: Breast tumor stiffness, which can be objectively and noninvasively evaluated by ultrasound elastography (UE), has been useful for the differentiation of benign and malignant breast lesions and the prediction of clinical outcomes. Liquid biopsy analyses, including cell-free tumor DNA (ctDNA), exhibit great potential for personalized treatment. This study aimed to investigate the correlations between the UE and ctDNA for early breast cancer diagnosis. METHODS: Breast tumor stiffness in 10 patients were assessed by shear wave elastography (SWE), and the ctDNA of eight collected plasma specimens with different tumor stiffness were analyzed by whole-genome sequencing (WGS). Subsequently, the distribution of carcinoma-associated fibroblasts (CAFs) was investigated by detecting the expression levels of alpha-smooth muscle actin (α-SMA) in tissues of breast lesions. We validated the function of discoidin domain receptor 2 (DDR2) in breast tumor CAFs by knockout of fibroblast activation protein (FAP) with different tumor stiffness during cancer progression in vitro and vivo. RESULTS: The UE estimates of tumor stiffness positively correlated with CAF-rich (α-SMA(+)) tumors (P
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Quant Imaging Med Surg
- Accession number :
- edsair.doi.dedup.....c763b60d0b253701e6e8871cd18618ca